gamma-Hydroxyvaleric acid
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| Synonyms |
γ-Hydroxyvaleric acid GVB |
| CAS Number | 13532-37-1 |
| PubChem (CID) | 114539 |
| ChemSpider | 102591 |
| ECHA InfoCard | 100.033.516 |
| Chemical and physical data | |
| Formula | C5H10O3 |
| Molar mass | 118.13 g/mol |
γ-Hydroxyvaleric acid (GHV), also known as 4-methyl-GHB, is a designer drug related to γ-hydroxybutyric acid (GHB). It is sometimes seen on the black market as a legal alternative to GHB, but with lower potency and higher toxicity,[1] properties which have tended to limit its recreational use.[2]
γ-Valerolactone (GVL) acts as a prodrug to GHV, analogously to how γ-butyrolactone (GBL) is a prodrug to GHB.[3]
See also
References
- ↑ Carter LP; Chen W; Wu H; Mehta AK; Hernandez RJ; Ticku MK; Coop A; Koek W; France CP (April 2005). "Comparison of the behavioral effects of gamma-hydroxybutyric acid (GHB) and its 4-methyl-substituted analog, gamma-hydroxyvaleric acid (GHV)". Drug and Alcohol Dependence. 78 (1): 91–9. doi:10.1016/j.drugalcdep.2004.10.002. PMID 15769562.
- ↑ Fred Smith (31 December 2004). Handbook of Forensic Drug Analysis. Academic Press. pp. 462–. ISBN 978-0-08-047289-8.
- ↑ Andresen-Streichert H, Jungen H, Gehl A, Müller A, Iwersen-Bergmann S (2013). "Uptake of gamma-valerolactone--detection of gamma-hydroxyvaleric acid in human urine samples". J Anal Toxicol. 37 (4): 250–4. doi:10.1093/jat/bkt013. PMID 23486087.
| Receptor (ligands) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (blockers) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
See also: GHBergics • Glutamatergics • Glycinergics | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receptor (ligands) |
| ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (blockers) | |||||||||||||||||||
| Enzyme (inhibitors) | |||||||||||||||||||
| Others | |||||||||||||||||||
See also: GABAergics • Glutamatergics • Glycinergics | |||||||||||||||||||
This article is issued from Wikipedia - version of the 1/29/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.